08-29-2017 10:06 AM CET - Health & Medicine

Cloud-Based Drug Discovery Platform Market to Develop Rapidly by 2026

Press release from: Persistence Market Research

On the basis of types of services cloud-based drug discovery platform market I segmented into Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS). IaaS offers data-center space, and servers, network equipment such as software for businesses and routers/switches. PaaS offers full hardware architecture and software framework. In SaaS process providers allow to access software over the net only.

Geographically, global cloud-based drug discovery market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America, Western Europe are the major shareholder of cloud-based drug discovery platform market. Asia pacific market for cloud-based drug discovery platform is expected to fuel the cloud-based drug discovery platform market in the near future.

Data management is a critical issue for the pharmaceutical industry. The pharmaceutical industry is rapidly restructuring its discovery business model to completely networked and integrated research and development in order to manage the huge data. This big data concept is main growth driver for the cloud-based drug discovery platform market.

Graphical representation is a dynamic and quick form of getting a result which is easy for decision making in a management level, understanding the demand of consumers, companies are offering cloud-based drug discovery platform accordingly. Cloud-based drug discover platform runts at zero lag time, that’s saves time for the users. This is another reason why pharmaceutical companies adopt cloud-based drug discover platform.

Request for more detailed information (TOC And Sample): www.persistencemarketresearch.com/samples/11020

Some of the key players operating in the cloud-based drug discovery platform market IBM Corp, Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec (Shanghai) Co., Ltd., dassault systèmes biovia ltd.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.
News-ID: 688398 • Views: 140
More releases More releases

You can edit or delete your press release here: